What Researchers Did
Researchers presented a case study of a 43-year-old man with severe lava-related burns complicated by persistent multidrug-resistant infections, including MRSA, who received hyperbaric oxygen therapy as an additional treatment.
What They Found
After 30 daily hyperbaric oxygen therapy sessions at 2.4 ATA for 90 minutes, alongside repeated debridement and targeted antibiotics, the patient achieved near-complete clearance of MRSA and Pseudomonas aeruginosa. The wound showed near-complete epithelialization, reaching approximately 90%, and functional recovery without any reported adverse events.
What This Means for Canadian Patients
For Canadian patients suffering from chronic burn injuries complicated by persistent multidrug-resistant infections, this case suggests that adjunctive hyperbaric oxygen therapy could be a beneficial treatment option. HBOT may help improve infection control and accelerate wound healing, potentially leading to better recovery outcomes for these challenging cases.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a single case report, these findings cannot be generalized to a broader patient population and require further validation through larger studies.